000 02388 a2200673 4500
005 20250518055849.0
264 0 _c20200622
008 202006s 0 0 eng d
022 _a1524-4539
024 7 _a10.1161/CIRCULATIONAHA.119.042685
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBerg, David D
245 0 0 _aHeart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus.
_h[electronic resource]
260 _bCirculation
_c11 2019
300 _a1569-1577 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Validation Study
650 0 4 _aAdamantane
_xanalogs & derivatives
650 0 4 _aAged
650 0 4 _aBenzhydryl Compounds
_xadverse effects
650 0 4 _aClinical Decision-Making
650 0 4 _aDecision Support Techniques
650 0 4 _aDiabetes Mellitus, Type 2
_xcomplications
650 0 4 _aDiabetic Cardiomyopathies
_xdiagnosis
650 0 4 _aDipeptides
_xtherapeutic use
650 0 4 _aDipeptidyl-Peptidase IV Inhibitors
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aGlucosides
_xadverse effects
650 0 4 _aHealth Status
650 0 4 _aHeart Failure
_xdiagnosis
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPatient Selection
650 0 4 _aPredictive Value of Tests
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aReproducibility of Results
650 0 4 _aRisk Assessment
650 0 4 _aRisk Factors
650 0 4 _aSodium-Glucose Transporter 2 Inhibitors
_xadverse effects
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
700 1 _aWiviott, Stephen D
700 1 _aScirica, Benjamin M
700 1 _aGurmu, Yared
700 1 _aMosenzon, Ofri
700 1 _aMurphy, Sabina A
700 1 _aBhatt, Deepak L
700 1 _aLeiter, Lawrence A
700 1 _aMcGuire, Darren K
700 1 _aWilding, John P H
700 1 _aJohanson, Per
700 1 _aJohansson, Peter A
700 1 _aLangkilde, Anna Maria
700 1 _aRaz, Itamar
700 1 _aBraunwald, Eugene
700 1 _aSabatine, Marc S
773 0 _tCirculation
_gvol. 140
_gno. 19
_gp. 1569-1577
856 4 0 _uhttps://doi.org/10.1161/CIRCULATIONAHA.119.042685
_zAvailable from publisher's website
999 _c30065921
_d30065921